Because the purpose of this endophenotype-based approach is to identify variants implicated in disease, we tested whether the PSEN1, p.E318G is associated with AD risk, tau/Aβ pathology or rate of cognitive decline in an APOE dependent manner. Here, PSEN1 is linked to Alzheimer disease.